Gamida Cell Ltd (GMDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GMDA | AMGN | BMY | VRTX | GILD |
| Company | Gamida Cell Ltd | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0395 | 290.84 | 58.35 | 454.30 | 89.81 |
| High | 0.0395 | 295.48 | 58.79 | 457.54 | 90.45 |
| Low | 0.0320 | 288.78 | 57.62 | 449.04 | 89.27 |
| Last | 0.0327 | 294.97 | 58.68 | 451.92 | 90.38 |
| Change | -0.0073 | +5.07 | +0.45 | +1.55 | +0.62 |
| % Change | -18.25% | +1.75% | +0.77% | +0.34% | +0.69% |
| Volume | 23,036,800 | 1,300,886 | 3,719,243 | 707,424 | 1,740,777 |
| 20-Day Average Volume | 23,288,775 | 2,903,212 | 12,222,408 | 1,328,008 | 7,321,684 |
| Previous Close | 0.0400 | 289.90 | 58.23 | 450.37 | 89.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2442 | 306.28 | 56.26 | 477.89 | 90.95 |
| 20-Day Raw Stochastic | 0.62% | 35.44% | 74.00% | 7.72% | 32.49% |
| 20-Day Relative Strength | 26.92% | 39.92% | 61.71% | 41.06% | 54.64% |
| Weighted Alpha | -70.94 | +4.01 | +27.35 | +18.21 | +27.01 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 72% Sell | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.42% since 03/28/24 | +3.75% since 11/15/24 | +4.36% since 11/15/24 | -3.20% since 11/15/24 | +2.09% since 11/15/24 |
| Low | 0.0303 on 04/01/24 | 275.56 on 11/19/24 | 55.84 on 11/18/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.0579 on 04/02/24 | 295.48 on 11/22/24 | 58.83 on 11/20/24 | 468.88 on 11/18/24 | 90.44 on 11/22/24 |
| 1-Month | |||||
| %Chg | -90.92% since 03/05/24 | -7.95% since 10/22/24 | +11.20% since 10/22/24 | -5.08% since 10/22/24 | +2.37% since 10/22/24 |
| Low | 0.0303 on 04/01/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.4200 on 03/21/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -89.74% since 01/05/24 | -9.34% since 08/22/24 | +23.20% since 08/22/24 | -6.07% since 08/22/24 | +18.90% since 08/22/24 |
| Low | 0.0303 on 04/01/24 | 275.56 on 11/19/24 | 47.38 on 08/23/24 | 445.00 on 11/21/24 | 75.91 on 08/23/24 |
| High | 0.4870 on 01/29/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -96.79% since 10/05/23 | -4.90% since 05/22/24 | +38.57% since 05/22/24 | +0.73% since 05/22/24 | +33.10% since 05/22/24 |
| Low | 0.0303 on 04/01/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 1.0500 on 10/06/23 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,037 | 155,830,816 | 118,100,752 | 115,983,328 | 111,864,840 |
| Shares Outstanding, K | 154,051 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 1,780,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -63,000,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 1,110,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -8,840,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.93 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.04 on 03/27/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 05/20/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.98 | 49.47 | 0.00 | 20.01 |